What is the cost of, and capacity covered by, the manufacturing arrangement with International Isotopes? Why have you not publicly disclosed this arrangement?
How much will the MIP-1095 Phase 2 trial and AZEDRA basket trial cost?
Why has the Company neither refinanced the Relistor non-recourse debt nor borrowed further against this valuable royalty stream to provide accretion (vs. management's seeming preference for dilutive equity issuances)?
Subscribe to our Free Newsletters!